Renal-Clearable Peptide-Functionalized Ba₂GdF₇ Nanoparticles for Positive Tumor-Targeting Dual-Mode Bioimaging

Area of Science:

• Nanotechnology
• Biomedical Imaging
• Materials Science

Background:

• Developing effective nanoprobes for tumor targeting while ensuring renal clearance is crucial for minimizing toxicity.
• Dual-mode bioimaging offers enhanced diagnostic accuracy compared to single-mode techniques.

Purpose of the Study:

• To design and evaluate epidermal growth factor receptor (EGFR)-targeted Ba2GdF7 nanoparticles for dual-mode magnetic resonance imaging (MRI) and X-ray computed tomography (CT) bioimaging.
• To assess the tumor-targeting efficacy, biocompatibility, and renal clearance of these novel nanoprobes.

Main Methods:

• Synthesis of 6.5 nm Ba2GdF7 nanoparticles functionalized with EGFR-targeted peptides via Gd-phosphonate coordinate bonds.
• In vitro evaluation of cytocompatibility and binding affinity with lung cancer cells.
• In vivo MRI and CT imaging studies in tumor-bearing models to assess targeting and contrast enhancement.
• Systematic in vivo experiments to evaluate renal clearance kinetics and overall biocompatibility.

Main Results:

• EGFR-targeted Ba2GdF7 nanoparticles demonstrated high binding affinity with lung cancer cells and desirable cytocompatibility.
• In vivo imaging confirmed accumulation and retention of nanoparticles within A549 lung carcinoma, enhancing both MR and CT contrast.
• The developed nanoprobes exhibited favorable in vivo renal clearance kinetics and reasonable biocompatibility.

Conclusions:

• EGFR-targeted Ba2GdF7 nanoparticles show significant potential as dual-mode imaging agents for positive tumor targeting.
• These nanoparticles offer a promising strategy for enhanced lung cancer diagnosis with improved safety profiles due to efficient renal clearance.